A pivotal trial of PLX-PAD in Japanese patients with critical limb ischemia

Trial Profile

A pivotal trial of PLX-PAD in Japanese patients with critical limb ischemia

Planning
Phase of Trial: Phase III

Latest Information Update: 12 Aug 2016

At a glance

  • Drugs PLX PAD (Primary)
  • Indications Ischaemia; Peripheral arterial disorders
  • Focus Registrational; Therapeutic Use
  • Sponsors Pluristem Therapeutics
  • Most Recent Events

    • 12 Aug 2016 New trial record
    • 02 Aug 2016 According to a Pluristem Therapeutics media release, the company reached an agreement with Japan's Pharmaceuticals and Medical Devices Agency (PMDA) on the protocol of this trial via Japan's accelerated regulatory pathway for regenerative medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top